Home 5 Lab Industry Report 5 FDA-lir 5 FDA Watch: 23andMe Continues to Spearhead Direct-to-Consumer Marketing of LDT Genetic Tests

FDA Watch: 23andMe Continues to Spearhead Direct-to-Consumer Marketing of LDT Genetic Tests

by | Apr 23, 2018

From - Laboratory Industry Report On March 6, the FDA announced its first ever approval of a direct-to-consumer breast cancer gene test… . . . read more

This content is exclusive to Lab Industry Report subscribers

Start a Free Triall for immediate access to this article and our entire archive of over 20 years of LIR reports.